References:
1. Cal M, Ayres‐de‐Campos D, Jauniaux EJIJoG, Obstetrics. International
survey of practices used in the diagnosis and management of placenta
accreta spectrum disorders. 2018;140(3):307-11.
2. Tan CH, Tay KH, Sheah K, Kwek K, Wong K, Tan HK, et al. Perioperative
endovascular internal iliac artery occlusion balloon placement in
management of placenta accreta. AJR Am J Roentgenol.
2007;189(5):1158-63.
3. Ye MY, Z.;Xue, M.;Deng, X. High-intensity focused ultrasound combined
with hysteroscopic resection for the treatment of placenta accreta.
BJOG: An International Journal of Obstetrics and Gynaecology.
2017;124:71-7.
4. Zeng C, Yang M, Ding Y, Duan S, Zhou Y. Placenta accreta spectrum
disorder trends in the context of the universal two-child policy in
China and the risk of hysterectomy. Int J Gynaecol Obstet.
2018;140(3):312-8.
5. Silver RM, Landon MB, Rouse DJ, Leveno KJ, Spong CY, Thom EA, et al.
Maternal morbidity associated with multiple repeat cesarean deliveries.
Obstet Gynecol. 2006;107(6):1226-32.
6. Timor-Tritsch IE, Monteagudo AJAjoo, gynecology. Unforeseen
consequences of the increasing rate of cesarean deliveries: early
placenta accreta and cesarean scar pregnancy. A review.
2012;207(1):14-29.
7. ACOG Committee opinion. Number 266, January 2002 : placenta accreta.
Obstet Gynecol. 2002;99(1):169-70.
8. Verspyck E, Resch B, Sergent F, Marpeau L. Surgical uterine
devascularization for placenta accreta: immediate and long-term
follow-up. Acta Obstet Gynecol Scand. 2005;84(5):444-7.
9. Legendre G, Zoulovits FJ, Kinn J, Senthiles L, Fernandez H.
Conservative management of placenta accreta: hysteroscopic resection of
retained tissues. J Minim Invasive Gynecol. 2014;21(5):910-3.
10. Kutuk MS, Ak M, Ozgun MT. Leaving the placenta in situ versus
conservative and radical surgery in the treatment of placenta accreta
spectrum disorders. Int J Gynaecol Obstet. 2018;140(3):338-44.
11. Sentilhes L, Kayem G, Chandraharan E, Palacios‐Jaraquemada J,
Jauniaux E, Diagnosis FPA, et al. FIGO consensus guidelines on placenta
accreta spectrum disorders: conservative management. 2018;140(3):291-8.
12. Jenne JW, Preusser T, Günther M. High-intensity focused ultrasound:
principles, therapy guidance, simulations and applications. Z Med Phys.
2012;22(4):311-22.
13. Jang HJ, Lee J-Y, Lee D-H, Kim W-H, Hwang JHJG, liver. Current and
future clinical applications of high-intensity focused ultrasound (HIFU)
for pancreatic cancer. 2010;4(Suppl 1):S57.
14. Zhu X, Deng X, Wan Y, Xiao S, Huang J, Zhang L, et al.
High-intensity focused ultrasound combined with suction curettage for
the treatment of cesarean scar pregnancy. Medicine (Baltimore).
2015;94(18):e854.
15. Fan TY, Zhang L, Chen W, Liu Y, He M, Huang X, et al. Feasibility of
MRI-guided high intensity focused ultrasound treatment for adenomyosis.
Eur J Radiol. 2012;81(11):3624-30.
16. Park MJ, Kim YS, Rhim H, Lim HK. Safety and therapeutic efficacy of
complete or near-complete ablation of symptomatic uterine fibroid tumors
by MR imaging-guided high-intensity focused US therapy. J Vasc Interv
Radiol. 2014;25(2):231-9.
17. CON-PAS registry. Middle-East Obstetrics and Gynecology Graduate
Education (MOGGE) Foundation.
https://www.mogge-obgyn.com/con-pas-registry. Last accessed: April 28th,
2020
18. . US National Heart, Lung and Blood Institute Quality Assessment
Tool for Before-After (Pre-Post) Studies With No Control Group [URL:
wwwnhlbinihgov/health-topics/study-quality-assessment-tools (accessed 9
April 2020]
19. Bai YL, X.;Li, Q.;Yin, N.;Fu, X.;Zhang, H.;Qi, H. High-intensity
focused ultrasound treatment of placenta accreta after vaginal delivery:
A preliminary study. Ultrasound in Obstetrics and Gynecology.
2016;47(4):492-8.
20. Jiang XFT, Q. L.;Yang, B. J.;Ye, F.;Cai, L.;Wang, X. Y.;Luo, X.;Bu,
H. High-intensity focused ultrasound combined procedures treatment of
retained placenta accreta with marked vascularity after abortion or
delivery. International Journal of Hyperthermia. 2019;36(1):421-7.
21. Liu YZ, W. W.;He, M.;Gong, C.;Xie, B.;Wen, X.;Li, D.;Zhang, L.
Adverse effect analysis of high-intensity focused ultrasound in the
treatment of benign uterine diseases. Int J Hyperthermia.
2018;35(1):56-61.
22. Buca D, Liberati M, Calì G, Forlani F, Caisutti C, Flacco ME, et al.
Influence of prenatal diagnosis of abnormally invasive placenta on
maternal outcome: systematic review and meta‐analysis. 2018;52(3):304-9.
23. Jauniaux E, Alfirevic Z, Bhide A, Belfort M, Burton G, Dornan S, et
al. Placenta praevia and placenta accreta: diagnosis and management.
Green-top Guideline No. 27a. 2018;126(1).
24. gynaecology CoOPJIjo, Gynaecology otoootIFo, Obstetrics. ACOG
committee opinion. Placenta accreta. Number 266, January 2002. American
College of Obstetricians and Gynecologists. 2002;77(1):77.
25. Eller A, Porter T, Soisson P, Silver RJBAIJoO, Gynaecology. Optimal
management strategies for placenta accreta. 2009;116(5):648-54.
26. Mohan B, Wander G, Bansal R, Mutti J, Tandon P, Juneja S, et al.
Intra-operative uterine artery embolization with caesarean delivery in
an adjoining operating theatre and catheter lab (OT/CL) complex vs.
conventional management in patients with abnormally invasive placenta: a
retrospective case control study. Journal of Obstetrics and Gynaecology.
2020;40(3):324-9.
27. Mohr‐Sasson A, Hochman R, Anteby M, Spira M, Castel E, Hendler I, et
al. Cesarean delivery with and without uterine artery embolization for
the management of placenta accreta spectrum disorder‐A comparative
study. 2020.
28. Babaei M, Kian MO, Naderi Z, Khodaverdi S, Raoofi Z, Javanmanesh F,
et al. Methotrexate infusion followed by uterine artery embolisation for
the management of placental adhesive disorders: a case series.
2019;74(5):378-83.
29. Yuan Q, Jin Y, Chen L, Ling L, Bai XmJIJoG, Obstetrics. Prophylactic
uterine artery embolization during cesarean delivery for placenta previa
complicated by placenta accreta. 2019.
30. Pan Y, Zhou X, Yang Z, Cui S, De W, Sun LJIJoG, et al. Retrospective
cohort study of prophylactic intraoperative uterine artery embolization
for abnormally invasive placenta. 2017;137(1):45-50.
31. Wang Z-w, Li X-g, Pan J, Zhang X-b, Shi H-f, Yang N, et al. Uterine
artery embolization for management of primary postpartum hemorrhage
associated with placenta accreta. 2016;31(4):228-32.
32. Niola R, Giurazza F, Nazzaro G, Silvestre M, Nasti G, Di Pasquale
MA, et al. Uterine artery embolization before delivery to prevent
postpartum hemorrhage. 2016;27(3):376-82.
33. D’Souza DL, Kingdom JC, Amsalem H, Beecroft JR, Windrim RC, Kachura
JRJCAoRJ. Conservative management of invasive placenta using combined
prophylactic internal iliac artery balloon occlusion and immediate
postoperative uterine artery embolization. 2015;66(2):179-84.
34. Duan X-H, Wang Y-L, Han X-W, Chen Z-M, Chu Q-J, Wang L, et al.
Caesarean section combined with temporary aortic balloon occlusion
followed by uterine artery embolisation for the management of placenta
accreta. 2015;70(9):932-7.
35. Lo TK, Yung W, Lau W, Law B, Lau S, Leung WJTJoM-F, et al. Planned
conservative management of placenta accreta–experience of a regional
general hospital. 2014;27(3):291-6.
36. Hwang SM, Jeon GS, Kim MD, Kim SH, Lee JT, Choi MJJEr. Transcatheter
arterial embolisation for the management of obstetric haemorrhage
associated with placental abnormality in 40 cases. 2013;23(3):766-73.
37. Chung MY, Cheng YK, Yu SC, Sahota DS, Leung TYJAoegS. Nonremoval of
an abnormally invasive placenta at cesarean section with postoperative
uterine artery embolization. 2013;92(11):1250-5.
38. Meyer N, Ward G, Chandraharan EJCMJ. Conservative approach to the
management of morbidly adherent placentae. 2012;57(1).
39. Li X, Wang Z, Chen J, Shi H, Zhang X, Pan J, et al. Uterine artery
embolization for the management of secondary postpartum haemorrhage
associated with placenta accreta. 2012;67(12):e71-e6.
40. Bouvier A, Sentilhes L, Thouveny F, Bouet P-E, Gillard P, Willoteaux
S, et al. Planned caesarean in the interventional radiology cath lab to
enable immediate uterine artery embolization for the conservative
treatment of placenta accreta. 2012;67(11):1089-94.
41. Soyer P, Morel O, Fargeaudou Y, Sirol M, Staub F, Boudiaf M, et al.
Value of pelvic embolization in the management of severe postpartum
hemorrhage due to placenta accreta, increta or percreta.
2011;80(3):729-35.
42. Barber Jr JT, Tressler TB, Willis GS, Martinez FJ, Peisner DB,
Goodman JD, et al. Arteriovenous malformation identification after
conservative management of placenta percreta with uterine artery
embolization and adjunctive therapy. 2011;204(5):e4-e8.
43. Jung HN, Shin SW, Choi S-J, Cho SK, Park KB, Park HS, et al. Uterine
artery embolization for emergent management of postpartum hemorrhage
associated with placenta accreta. 2011;52(6):638-42.
44. Park JK, Shin TB, Baek JC, Shin JK, Choi WJ, Lee SA, et al. Failure
of uterine artery embolization for controlling postpartum hemorrhage.
2011;37(8):971-8.
45. Sivan E, Spira M, Achiron R, Rimon U, Golan G, Mazaki-Tovi S, et al.
Prophylactic pelvic artery catheterization and embolization in women
with placenta accreta: can it prevent cesarean hysterectomy?
2010;27(06):455-61.
46. Yu M, Liu X, Dai Q, Cui Q, Jin Z, Lang JJZyxkxyxbAAMS. Diagnosis and
treatment of placenta accreta in the second trimester of pregnancy.
2010;32(5):501-4.
47. Diop AN, Chabrot P, Bertrand A, Constantin JM, Cassagnes L, Storme
B, et al. Placenta accreta: management with uterine artery embolization
in 17 cases. 2010;21(5):644-8.
48. Sentilhes L, Gromez A, Clavier E, Resch B, Verspyck E, Marpeau LJO,
et al. Predictors of failed pelvic arterial embolization for severe
postpartum hemorrhage. 2009;113(5):992-9.
49. Chen M, Liu X, You Y, Wang X, Li T, Luo H, et al. Internal Iliac
Artery Balloon Occlusion for Placenta Previa and Suspected Placenta
Accreta: A Randomized Controlled Trial. 2020;135(5):1112-9.
50. Liu J, Wang Y, Jiao D, Zhang W, Han XJC, radiology i. Prophylactic
Occlusion Balloon Placement in the Abdominal Aorta Combined with Uterine
or Ovarian Artery Embolization for the Prevention of Cesarean
Hysterectomy Due to Placenta Accreta: A Retrospective Study.
2019;42(6):829-34.
51. Zheng Z, Xie X, Hou Y, Xie P, Yu X, Xie LJC, et al. Intraoperative
infrarenal aortic balloon occlusion in pregnancies with placenta
accreta, increta, and percreta. 2019;46(5):704.
52. Duan X, Chen P, Han X, Wang Y, Chen Z, Zhang X, et al. Intermittent
aortic balloon occlusion combined with cesarean section for the
treatment of patients with placenta previa complicated by placenta
accreta: A retrospective study. 2018;44(9):1752-60.
53. Mei Y, Zhao H, Zhou H, Jing H, Lin YJBp, childbirth. Comparison of
infrarenal aortic balloon occlusion with internal iliac artery balloon
occlusion for patients with placenta accreta. 2019;19(1):147.
54. Dai Mj, Jin Gx, Lin Jh, Zhang Y, Chen Yy, Zhang XbJIJoG, et al.
Pre‐cesarean prophylactic balloon placement in the internal iliac artery
to prevent postpartum hemorrhage among women with pernicious placenta
previa. 2018;142(3):315-20.
55. Sun W, Duan S, Xin G, Xiao J, Hong F, Hong H, et al. Safety and
efficacy of preoperative abdominal aortic balloon occlusion in placenta
increta and/or percreta. 2018;222:75-84.
56. Luo F, Xie L, Xie P, Liu S, Zhu YJTJoO, Gynecology. Intraoperative
aortic balloon occlusion in patients with placenta previa and/or
placenta accreta: a retrospective study. 2017;56(2):147-52.
57. Angileri SA, Mailli L, Raspanti C, Ierardi AM, Carrafiello G, Belli
A-MJLrm. Prophylactic occlusion balloon placement in internal iliac
arteries for the prevention of postpartum haemorrhage due to morbidly
adherent placenta: short term outcomes. 2017;122(10):798-806.
58. Cui S, Zhi Y, Cheng G, Zhang K, Zhang L, Shen LJIJoG, et al.
Retrospective analysis of placenta previa with abnormal placentation
with and without prophylactic use of abdominal aorta balloon occlusion.
2017;137(3):265-70.
59. Wu Q, Liu Z, Zhao X, Liu C, Wang Y, Chu Q, et al. Outcome of
pregnancies after balloon occlusion of the infrarenal abdominal aorta
during caesarean in 230 patients with placenta praevia accreta.
2016;39(11):1573-9.
60. Panici PB, Anceschi M, Borgia ML, Bresadola L, Masselli G, Parasassi
T, et al. Intraoperative aorta balloon occlusion: fertility preservation
in patients with placenta previa accreta/increta. 2012;25(12):2512-6.
61. Thon S, McLintic A, Wagner YJIjooa. Prophylactic endovascular
placement of internal iliac occlusion balloon catheters in parturients
with placenta accreta: a retrospective case series. 2011;20(1):64-70.
62. Sadashivaiah J, Wilson R, Thein A, McLure H, Hammond C, Lyons
GJIjooa. Role of prophylactic uterine artery balloon catheters in the
management of women with suspected placenta accreta. 2011;20(4):282-7.
63. Tan CH, Tay KH, Sheah K, Kwek K, Wong K, Tan HK, et al.
Perioperative endovascular internal iliac artery occlusion balloon
placement in management of placenta accreta. 2007;189(5):1158-63.
64. Zhao B, Lv M, Dong T, Chen Y, Xi F, Lv W, et al. Transverse parallel
compression suture: a new suturing method for successful treating
pernicious placenta previa during cesarean section. 2020;301(2):465-72.
65. El Gelany S, Ibrahim EM, Abdelraheim AR, Khalifa EM, Abdelhakium AK,
Yousef AM, et al. Management of bleeding from morbidly adherent placenta
during elective repeat caesarean section: retrospective-record-based
study. 2019;19(1):106.
66. Mohamed MAJTJoM-F, Medicine N. Lower segment folding as novel
technique to control bleeding in cases of morbidly adherent placenta.
2019:1-5.
67. El-Agwany ASJIJGO. Conservative treatment of placenta previa accreta
with cervical isthmic opposition suturing followed by bilateral internal
iliac artery ligation. 2016;135:329-30.
68. Kelekci S, Ekmekci E, Aydogmus S, Gencdal SJM. A comprehensive
surgical procedure in conservative management of placenta accreta: a
case series. 2015;94(7).
69. Shazly SAE, Badee AY, Ali MKJA, Obstetrics NZJo, Gynaecology. The
use of multiple 8 compression suturing as a novel procedure to preserve
fertility in patients with placenta accreta: case series.
2012;52(4):395-9.
70. Arduini M, Epicoco G, Clerici G, Bottaccioli E, Arena S, Affronti
GJIJoG, et al. B‐Lynch suture, intrauterine balloon, and endouterine
hemostatic suture for the management of postpartum hemorrhage due to
placenta previa accreta. 2010;108(3):191-3.
71. Shahin AY, Farghaly TA, Mohamed SA, Shokry M, Abd‐El‐Aal DEM,
Youssef MAJIJoG, et al. Bilateral uterine artery ligation plus B‐Lynch
procedure for atonic postpartum hemorrhage with placenta accreta.
2010;108(3):187-90.
72. Verspyck E, Resch B, Sergent F, Marpeau LJAoegS. Surgical uterine
devascularization for placenta accreta: immediate and long‐term
follow‐up. 2005;84(5):444-7.
73. Palacios Jaraquemada JM, Pesaresi M, Nassif JC, Hermosid SJAoegS.
Anterior placenta percreta: surgical approach, hemostasis and uterine
repair. 2004;83(8):738-44.
74. Kutuk MS, Ak M, Ozgun MTJIJoG, Obstetrics. Leaving the placenta in
situ versus conservative and radical surgery in the treatment of
placenta accreta spectrum disorders. 2018;140(3):338-44.
75. Provansal M, Courbiere B, Agostini A, D’Ercole C, Boubli L, Bretelle
FJIJoG, et al. Fertility and obstetric outcome after conservative
management of placenta accreta. 2010;109(2):147-50.
76. Bennett MJ, Townsend LJA, Obstetrics NZJo, Gynaecology. Conservative
management of clinically diagnosed placenta accreta following vaginal
delivery. 2009;49(6):647-9.
77. Bretelle F, Courbière B, Mazouni C, Agostini A, Cravello L, Boubli
L, et al. Management of placenta accreta: morbidity and outcome.
2007;133(1):34-9.
78. Matsumura N, Inoue T, Fukuoka M, Sagawa N, Fujii SJJoO, Research G.
Changes in the serum levels of human chorionic gonadotropin and the
pulsatility index of uterine arteries during conservative management of
retained adherent placenta. 2000;26(2):81-7.
79. Lin K, Qin J, Xu K, Hu W, Lin JJAog, obstetrics. Methotrexate
management for placenta accreta: a prospective study.
2015;291(6):1259-64.
80. Mussalli GM, Shah J, Berck DJ, Elimian A, Tejani N, Manning FAJJoP.
Placenta accreta and methotrexate therapy: three case reports.
2000;20(5):331-4.
81. Palacios-Jaraquemada JM, Fiorillo A, Hamer J, Martínez M, Bruno
CJTJoM-F, Medicine N. Placenta accreta spectrum: a hysterectomy can be
prevented in almost 80% of cases using a resective-reconstructive
technique. 2020:1-8.
82. Cırpan T, Akdemir A, Okmen F, Hortu I, Ekici H, Imamoglu MJTJoM-F,
et al. Effectiveness of segmental resection technique in the treatment
of placenta accreta spectrum. 2019:1-7.
83. Abo-Elroose AA-E, Ahmed MR, Shaaban MM, Ghoneim HM, Mohamed
TYJTJoM-F, Medicine N. Triple P with T-shaped lower segment suture; an
effective novel alternative to hysterectomy in morbidly adherent
anterior placenta previa. 2019:1-5.
84. Wei Y, Cao Y, Yu Y, Wang ZJAog, obstetrics. Evaluation of a modified
“Triple-P” procedure in women with morbidly adherent placenta after
previous caesarean section. 2017;296(4):737-43.
85. Viñas MT, Chandraharan E, Moneta M, Belli AJCr. The role of
interventional radiology in reducing haemorrhage and hysterectomy
following caesarean section for morbidly adherent placenta.
2014;69(8):e345-e51.
86. Chandraharan E, Rao S, Belli AM, Arulkumaran SJIJoG, Obstetrics. The
Triple‐P procedure as a conservative surgical alternative to peripartum
hysterectomy for placenta percreta. 2012;117(2):191-4.